POSTED IN NEWS | 10. DECEMBER 2021
Sarcoids in horses: Next milestone in cancer therapy

We are glad to announce that scientists from our biotechnology company BlueSky Immunotherapies GmbH (Ltd.) have achieved great success in completely and permanently eliminating equine sarcoids and bovine papillomavirus that causes this aggressive form of skin cancer that horses often suffer from.
By using its proprietary delNS technology, BlueSky Immunotherapies has created a viral vector platform for the induction of interferon and expression of tumor antigens. delNS vectors have many properties for overcoming the immunosuppressive environment of tumors. In the future, the delNS-based immunotherapy could be an effective alternative for humans when chemotherapy and surgical excision only have limited effects.